Skip to main content
Erschienen in: Irish Journal of Medical Science (1971 -) 4/2015

01.12.2015 | Original Article

The effect of Glutathione-S-transferases in the susceptibility to bladder cancer

verfasst von: G. G. Ceylan, C. Ceylan, S. Taşdemir, A. Gözalan

Erschienen in: Irish Journal of Medical Science (1971 -) | Ausgabe 4/2015

Einloggen, um Zugang zu erhalten

Abstract

Background

Urinary bladder cancer is a quite common cancer type in men and women all over the world. Genetic polymorphisms of xenobiotic-metabolizing enzymes could increase individual susceptibility to various cancer types.

Aims

The aim of our study is to evaluate the rate of these polymorphisms in a group of patients from Central Anatolia.

Methods

Our study subjects consist of 65 men with histopathologically confirmed bladder TCC and 70 cancer-free control subjects. Restriction fragment length polymorphism (RFLP) method was used for the detection of polymorphisms of GSTT1 and GSTM1.

Results

There was no association between bladder cancer and GSTM1 polymorphism (ORs = 0.64, 95 % CI = 0.32–1.29), but the probability of bladder cancer in patients with GSTT1 null genotype (67.9 %), was significantly higher from the probability of bladder cancer with GSTT1 normal genotype (43.0 %) statistically (ORs = 2.8, 95 % CI = 1.16–6.75).

Conclusion

Polymorphisms of these genes have been assessed to evaluate the relative risk of various cancers. Our intention is to continue this study with larger series of bladder cancer patients in a group of Turkish population from Central Anatolia.
Literatur
1.
Zurück zum Zitat Ferlay J, Bray F, Pisani P, Parkin DM, GLOBOCAN (2002) Cancer incidence, mortality and prevalence worldwide. IARC cancer base no. 5, version 1.0. International agency for research on cancer Ferlay J, Bray F, Pisani P, Parkin DM, GLOBOCAN (2002) Cancer incidence, mortality and prevalence worldwide. IARC cancer base no. 5, version 1.0. International agency for research on cancer
2.
Zurück zum Zitat Konety BR, Williams RD (2004) Superficial transitional (Ta/T1/CIS) cell carcinoma of the bladder. BJU Int 94:18–21CrossRefPubMed Konety BR, Williams RD (2004) Superficial transitional (Ta/T1/CIS) cell carcinoma of the bladder. BJU Int 94:18–21CrossRefPubMed
3.
Zurück zum Zitat Jemal A, Thomas A, Murray T, Thun M (2002) Cancer statistics 2002. CA Cancer J Clin 52:23–47CrossRefPubMed Jemal A, Thomas A, Murray T, Thun M (2002) Cancer statistics 2002. CA Cancer J Clin 52:23–47CrossRefPubMed
4.
Zurück zum Zitat Heney NM (1992) Natural history of superficial bladder cancer. Prognostic features and long-term disease course. Urol Clin NorthAm 19:429–433 Heney NM (1992) Natural history of superficial bladder cancer. Prognostic features and long-term disease course. Urol Clin NorthAm 19:429–433
5.
Zurück zum Zitat Cohen SM, Shirai T, Steineck G (2000) Epidemiology and etiology of premalignant and malignant urothelial changes. Scand J Urol Nephrol (Suppl) 205:105–115CrossRef Cohen SM, Shirai T, Steineck G (2000) Epidemiology and etiology of premalignant and malignant urothelial changes. Scand J Urol Nephrol (Suppl) 205:105–115CrossRef
6.
Zurück zum Zitat Stern MC, Johnson LR, Bell DA, Taylor JA (2000) XPD Codon 751 polymorphism, metabolism genes, smoking, and bladder cancer risk. Cancer Epidemiol Biomarkers Prev 11:1004–1011 Stern MC, Johnson LR, Bell DA, Taylor JA (2000) XPD Codon 751 polymorphism, metabolism genes, smoking, and bladder cancer risk. Cancer Epidemiol Biomarkers Prev 11:1004–1011
7.
Zurück zum Zitat Sanyal S, Festa F, Sakano S et al (2004) Polymorphisms in DNA repair and metabolic genes in bladder cancer. Carcinogenesis 25:729–734CrossRefPubMed Sanyal S, Festa F, Sakano S et al (2004) Polymorphisms in DNA repair and metabolic genes in bladder cancer. Carcinogenesis 25:729–734CrossRefPubMed
8.
Zurück zum Zitat Safarinejad MR, Shafiei N, Safarinejad S (2010) The association of glutathione-S-transferase gene polymorphisms (GSTM1, GSTT1, GSTP1) with idiopathic male infertility. J Hum Genet 55:565–570CrossRefPubMed Safarinejad MR, Shafiei N, Safarinejad S (2010) The association of glutathione-S-transferase gene polymorphisms (GSTM1, GSTT1, GSTP1) with idiopathic male infertility. J Hum Genet 55:565–570CrossRefPubMed
9.
Zurück zum Zitat Karagas MR, Park S, Warren A, Hamilton J, Nelson HH, Mott LA, Kelsey KT (2005) Gender, smoking, glutathione-S-transferase variants and bladder cancer incidence: a population-based study. Cancer Lett 219:63–69CrossRefPubMed Karagas MR, Park S, Warren A, Hamilton J, Nelson HH, Mott LA, Kelsey KT (2005) Gender, smoking, glutathione-S-transferase variants and bladder cancer incidence: a population-based study. Cancer Lett 219:63–69CrossRefPubMed
10.
Zurück zum Zitat Srivastava DS, Kumar A, Mittal B, Mittal RD (2004) Polymorphism of GSTM1 and GSTT1 genes in bladder cancer: a study from North India. Arch Toxicol 78:430–434CrossRefPubMed Srivastava DS, Kumar A, Mittal B, Mittal RD (2004) Polymorphism of GSTM1 and GSTT1 genes in bladder cancer: a study from North India. Arch Toxicol 78:430–434CrossRefPubMed
11.
Zurück zum Zitat Shao J, Gu M, Zhang Z, Xu Z, Hu Q, Qian L (2008) Genetic variants of the cytochrome P450 and glutathione S-transferase associated with risk of bladder cancer in a south-eastern Chinese population. Int J Urol 15:216–221CrossRefPubMed Shao J, Gu M, Zhang Z, Xu Z, Hu Q, Qian L (2008) Genetic variants of the cytochrome P450 and glutathione S-transferase associated with risk of bladder cancer in a south-eastern Chinese population. Int J Urol 15:216–221CrossRefPubMed
12.
Zurück zum Zitat Sobti RC, Al-Badran AI, Sharma S, Sharma SK, Krishan A, Mohan H (2005) Genetic polymorphisms of CYP2D6, GSTM1, and GSTT1 genes and bladder cancer risk in North India. Cancer Genet Cytogenet 156:68–73CrossRefPubMed Sobti RC, Al-Badran AI, Sharma S, Sharma SK, Krishan A, Mohan H (2005) Genetic polymorphisms of CYP2D6, GSTM1, and GSTT1 genes and bladder cancer risk in North India. Cancer Genet Cytogenet 156:68–73CrossRefPubMed
13.
Zurück zum Zitat McGrath M, Michaud D, De Vivo I (2006) Polymorphisms in GSTT1, GSTM1, NAT1 and NAT2 genes and bladder cancer risk in men and women. BMC Cancer 6:239PubMedCentralCrossRefPubMed McGrath M, Michaud D, De Vivo I (2006) Polymorphisms in GSTT1, GSTM1, NAT1 and NAT2 genes and bladder cancer risk in men and women. BMC Cancer 6:239PubMedCentralCrossRefPubMed
14.
Zurück zum Zitat Salagovic J, Kalina I, Stubna J, Habalová V, Hrivnák M, Valanský L, Kohút A, Biros E (1998) Genetic polymorphism of glutathione S-transferase M1 and T1 and risk factor in lung and bladder cancer. Neoplasma 45:312–317PubMed Salagovic J, Kalina I, Stubna J, Habalová V, Hrivnák M, Valanský L, Kohút A, Biros E (1998) Genetic polymorphism of glutathione S-transferase M1 and T1 and risk factor in lung and bladder cancer. Neoplasma 45:312–317PubMed
15.
Zurück zum Zitat Singh M, Shah PP, Singh AP, Ruwali M, Mathur N, Pant MC, Parmar D (2008) Association of genetic polymorphisms in glutathione S-transferases and susceptibility to head and neck cancer. Mutat Res 638:184–194CrossRefPubMed Singh M, Shah PP, Singh AP, Ruwali M, Mathur N, Pant MC, Parmar D (2008) Association of genetic polymorphisms in glutathione S-transferases and susceptibility to head and neck cancer. Mutat Res 638:184–194CrossRefPubMed
16.
Zurück zum Zitat Smits KM, Gaspari L, Weijenberg MP et al (2003) Interaction between smoking, GSTM1 deletion, and colorectal cancer: results from the GSEC study. Biomarkers 8:299–310CrossRefPubMed Smits KM, Gaspari L, Weijenberg MP et al (2003) Interaction between smoking, GSTM1 deletion, and colorectal cancer: results from the GSEC study. Biomarkers 8:299–310CrossRefPubMed
17.
Zurück zum Zitat Lee SJ, Cho SH, Park SK et al (2002) Combined effect of glutathione S-transferase M1 and T1 genotypes on bladder cancer risk. Cancer Lett 28(177):173–179CrossRef Lee SJ, Cho SH, Park SK et al (2002) Combined effect of glutathione S-transferase M1 and T1 genotypes on bladder cancer risk. Cancer Lett 28(177):173–179CrossRef
18.
Zurück zum Zitat Steinhoff C, Franke KH, Golka K, Thier R, Römer HC, Rötzel C, Ackermann R, Schulz WA (2000) Glutathione transferase isozyme genotypes in patients with prostate and bladder carcinoma. Arch Toxicol 74:521–526CrossRefPubMed Steinhoff C, Franke KH, Golka K, Thier R, Römer HC, Rötzel C, Ackermann R, Schulz WA (2000) Glutathione transferase isozyme genotypes in patients with prostate and bladder carcinoma. Arch Toxicol 74:521–526CrossRefPubMed
19.
Zurück zum Zitat Abdel-Rahman SZ, Anwar WA, Abdel-Aal WE, Mostafa HM, Au WW (1998) GSTM1 and GSTT1 genes are potential risk modifiers for bladder cancer. Cancer Detect Prev 22:129–138CrossRefPubMed Abdel-Rahman SZ, Anwar WA, Abdel-Aal WE, Mostafa HM, Au WW (1998) GSTM1 and GSTT1 genes are potential risk modifiers for bladder cancer. Cancer Detect Prev 22:129–138CrossRefPubMed
20.
Zurück zum Zitat Zeng FF, Liu SY, Wei W et al (2010) Genetic polymorphisms of glutathione S-transferase T1 and bladder cancer risk: a meta-analysis. Clin Exp Med. 10:59–68CrossRefPubMed Zeng FF, Liu SY, Wei W et al (2010) Genetic polymorphisms of glutathione S-transferase T1 and bladder cancer risk: a meta-analysis. Clin Exp Med. 10:59–68CrossRefPubMed
21.
Zurück zum Zitat Franekova M, Halasova E, Bukovska E, Luptak J, Dobrota D (2008) Gene polymorphisms in bladder cancer. Urol Oncol 26(1):1–8CrossRefPubMed Franekova M, Halasova E, Bukovska E, Luptak J, Dobrota D (2008) Gene polymorphisms in bladder cancer. Urol Oncol 26(1):1–8CrossRefPubMed
22.
Zurück zum Zitat Katoh T, Inatomi H, Kim H, Yang M, Matsumoto T, Kawamoto T (1998) Effects of glutathione S-transferase (GST) M1 and GSTT1 genotypes on urothelial cancer risk. Cancer Lett 132:147–152CrossRefPubMed Katoh T, Inatomi H, Kim H, Yang M, Matsumoto T, Kawamoto T (1998) Effects of glutathione S-transferase (GST) M1 and GSTT1 genotypes on urothelial cancer risk. Cancer Lett 132:147–152CrossRefPubMed
Metadaten
Titel
The effect of Glutathione-S-transferases in the susceptibility to bladder cancer
verfasst von
G. G. Ceylan
C. Ceylan
S. Taşdemir
A. Gözalan
Publikationsdatum
01.12.2015
Verlag
Springer London
Erschienen in
Irish Journal of Medical Science (1971 -) / Ausgabe 4/2015
Print ISSN: 0021-1265
Elektronische ISSN: 1863-4362
DOI
https://doi.org/10.1007/s11845-014-1200-6

Weitere Artikel der Ausgabe 4/2015

Irish Journal of Medical Science (1971 -) 4/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.